Evidence map›Paper›PMID 34599921›Full record

ArticlePreventive medicine2021

Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study.

Rebecca Wilson, Harriet Quinn-Scoggins, Yvonne Moriarty, Jacqueline Hughes, Mark Goddard, Rebecca Cannings-John, Victoria Whitelock, Katriina L Whitaker, Detelina Grozeva, Julia Townson and 8 more

Abstract read
In one paragraph

Article in Preventive medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Recommendations for a Communication Strategy to Support Informed Decision-Making About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Rebecca WilsonCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: WilsonR13@Cardiff.ac.uk.
Harriet Quinn-ScogginsPRIME Centre Wales, Division of Population Medicine, School of Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: Quinn-ScogginsHD@Cardiff.ac.uk.
Yvonne MoriartyCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: MoriartyY@Cardiff.ac.uk.
Jacqueline HughesCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: HughesJ33@Cardiff.ac.uk.
Mark GoddardCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: GoddardM@Cardiff.ac.uk.
Rebecca Cannings-JohnCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: CanningsRL@Cardiff.ac.uk.
Victoria WhitelockCancer Intelligence, Cancer Research UK, 2 Redman Place, London, E20 1JQ, UK. Electronic address: Victoria.Whitelock@Cancer.org.uk.
Katriina L WhitakerSchool of Health Sciences, University of Surrey, Guildford, UK. Electronic address: K.Whitaker@Surrey.ac.uk.
Detelina GrozevaCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: GrozevaD@Cardiff.ac.uk.
Julia TownsonCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: Townson@Cardiff.ac.uk.
Kirstie OsborneCancer Intelligence, Cancer Research UK, 2 Redman Place, London, E20 1JQ, UK. Electronic address: Kirstie.Osborne@Cancer.org.uk.
Stephanie SmitsDivision of Population Medicine, School of Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: SmitsSE@Cardiff.ac.uk.
Michael RoblingCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK; DECIPHer (Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement), School of Social Sciences, Cardiff University, 1-3 Museum Place, Cardiff, UK. Electronic address: RoblingMR@Cardiff.ac.uk.
Julie HepburnPublic Involvement Community, Health and Care Research Wales Support Centre, Castlebridge 4, 15-19, Cowbridge Road East, Cardiff CF11 9AB, UK.
Graham MooreDECIPHer (Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement), School of Social Sciences, Cardiff University, 1-3 Museum Place, Cardiff, UK. Electronic address: MooreG@Cardiff.ac.uk.
Ardiana GjiniPublic Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff CF10 4BZ, UK; Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: Ardiana.Gjini@Wales.nhs.uk.
Kate BrainPRIME Centre Wales, Division of Population Medicine, School of Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK. Electronic address: BrainKE@Cardiff.ac.uk.
Jo WallerCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College London, Great Maze Pond, London SE1 9RT, UK. Electronic address: Jo.Waller@KCL.ac.uk.

Funding

Cancer Research UK 25350Medical Research Council MR/K023233/1
6 · The paper itself

Abstract

Worldwide, cancer screening faced significant disruption in 2020 due to the COVID-19 pandemic. If this has led to changes in public attitudes towards screening and reduced intention to participate, there is a risk of long-term adverse impact on cancer outcomes. In this study, we examined previous participation and future intentions to take part in cervical and colorectal cancer (CRC) screening following the first national lockdown in the UK. Overall, 7543 adults were recruited to a cross-sectional online survey in August-September 2020. Logistic regression analyses were used to identify correlates of strong screening intentions among 2319 participants eligible for cervical screening and 2502 eligible for home-based CRC screening. Qualitative interviews were conducted with a sub-sample of 30 participants. Verbatim transcripts were analysed thematically. Of those eligible, 74% of survey participants intended to attend cervical screening and 84% intended to complete home-based CRC screening when next invited. Thirty percent and 19% of the cervical and CRC samples respectively said they were less likely to attend a cancer screening appointment now than before the pandemic. Previous non-participation was the strongest predictor of low intentions for cervical (aOR 26.31, 95% CI: 17.61-39.30) and CRC (aOR 67.68, 95% CI: 33.91-135.06) screening. Interview participants expressed concerns about visiting healthcare settings but were keen to participate when screening programmes resumed. Intentions to participate in future screening were high and strongly associated with previous engagement in both programmes. As screening services recover, it will be important to monitor participation and to ensure people feel safe to attend.

Indexed as

Colorectal NeoplasmsCOVID-19Uterine Cervical NeoplasmsAdultCommunicable Disease ControlCross-Sectional StudiesEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHumansIntentionMass ScreeningPandemicsSARS-CoV-2Cancer screeningCervical screeningColorectal screeningCOVID-19Mixed-methods study

Identifiers

PMID34599921
PMCPMC8480143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.